ETF Holdings Breakdown of REGN

Stock Name	Regeneron Pharmaceuticals Inc
Ticker	REGN(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US75886F1075
LEI	549300RCBFWIRX3HYQ56

News associated with REGN

Cyndeo Wealth Partners LLC Decreases Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Cyndeo Wealth Partners LLC lessened its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 9.5% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 677 shares of the biopharmaceutical company’s stock after selling 71 shares during the period. Cyndeo Wealth Partners LLC’s holdings […] - 2025-06-18 08:50:55
Exchange Traded Concepts LLC Lowers Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Exchange Traded Concepts LLC decreased its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 45.6% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 3,352 shares of the biopharmaceutical company’s stock after selling 2,807 shares during the quarter. Exchange Traded […] - 2025-06-18 08:13:06
Pallas Capital Advisors LLC Makes New Investment in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Pallas Capital Advisors LLC purchased a new position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, Holdings Channel.com reports. The fund purchased 671 shares of the biopharmaceutical company’s stock, valued at approximately $426,000. Several other institutional investors and hedge funds also recently added to or reduced their stakes in […] - 2025-06-13 08:38:52
Park Avenue Securities LLC Has $938,000 Stock Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Park Avenue Securities LLC cut its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 26.7% during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,480 shares of the biopharmaceutical company’s stock after selling 539 shares during the period. Park Avenue Securities […] - 2025-06-13 07:47:00
NBC Securities Inc. Acquires New Stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): NBC Securities Inc. bought a new position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the 1st quarter, according to its most recent filing with the SEC. The institutional investor bought 123 shares of the biopharmaceutical company’s stock, valued at approximately $78,000. Other hedge funds have also made changes to their positions in the […] - 2025-06-11 08:01:04
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by Miracle Mile Advisors LLC: Miracle Mile Advisors LLC increased its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 68.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,366 shares of the biopharmaceutical company’s stock after acquiring an additional 962 shares during the quarter. Miracle Mile […] - 2025-06-10 09:42:46
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Shares Acquired by UMB Bank n.a.: UMB Bank n.a. boosted its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 17.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,041 shares of the biopharmaceutical company’s stock after purchasing an additional 157 shares during the quarter. UMB […] - 2025-06-10 09:00:58
Gateway Investment Advisers LLC Purchases 113 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Gateway Investment Advisers LLC lifted its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 13.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 925 shares of the biopharmaceutical company’s stock after buying an additional 113 shares during the period. […] - 2025-06-10 08:24:52
Regeneron Pharma To Present At Goldman Sachs Global Healthcare Conference; Webcast At 10:40 AM ET: (RTTNews) - Regeneron Pharmaceuticals (REGN) will present at the Goldman Sachs 46th Annual Global Healthcare Conference. - 2025-06-09 13:40:35
Merit Financial Group LLC Purchases 761 Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Merit Financial Group LLC grew its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 87.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 1,629 shares of the biopharmaceutical company’s stock after purchasing an additional 761 shares during the quarter. […] - 2025-06-08 08:50:53
BMO Capital Markets Issues Pessimistic Forecast for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price objective reduced by equities researchers at BMO Capital Markets from $800.00 to $600.00 in a note issued to investors on Monday,Benzinga reports. The brokerage currently has an “outperform” rating on the biopharmaceutical company’s stock. BMO Capital Markets’ price target indicates a potential upside of 22.99% […] - 2025-06-04 05:42:45
Citigroup Cuts Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $650.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its price target cut by Citigroup from $700.00 to $650.00 in a research note released on Monday,Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. REGN has been the topic of a number of other research reports. JPMorgan Chase & Co. cut their price […] - 2025-06-03 05:52:46
Royal Bank of Canada Reaffirms “Outperform” Rating for Regeneron Pharmaceuticals (NASDAQ:REGN): Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Royal Bank of Canada in a research report issued on Tuesday,Benzinga reports. They currently have a $943.00 price objective on the biopharmaceutical company’s stock. Royal Bank of Canada’s target price indicates a potential upside of 59.33% from the […] - 2025-05-29 05:36:47
Benjamin Graham Detailed Fundamental Analysis - REGN: Below is Validea's guru fundamental report for REGENERON PHARMACEUTICALS INC (REGN). Of the 22 guru strategies we follow, REGN rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value methodology screens for stocks that hav - 2025-05-26 13:35:02
Regeneron Pharmaceuticals (NASDAQ:REGN) Shares Gap Down Following Weak Earnings: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) gapped down before the market opened on Tuesday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $610.86, but opened at $561.75. Regeneron Pharmaceuticals shares last traded at $558.22, with a volume of 229,725 shares trading hands. The biopharmaceutical […] - 2025-05-01 05:18:54
Truist Financial Lowers Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target to $975.00: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price target reduced by equities research analysts at Truist Financial from $1,004.00 to $975.00 in a note issued to investors on Wednesday,Benzinga reports. The firm presently has a “buy” rating on the biopharmaceutical company’s stock. Truist Financial’s price target indicates a potential upside of 62.57% from […] - 2025-04-25 07:28:48
Regeneron Pharmaceuticals (NASDAQ:REGN) Upgraded at Canaccord Genuity Group: Canaccord Genuity Group upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a hold rating to a strong-buy rating in a research note published on Tuesday,Zacks.com reports. Several other equities research analysts have also recently commented on REGN. JPMorgan Chase & Co. cut their price target on shares of Regeneron Pharmaceuticals from $1,100.00 to […] - 2025-04-25 07:28:48
Regeneron Pharma Partners With FujiFilm Diosynth To Boost Capacity At $3 Bln Investment: (RTTNews) - Regeneron Pharma, Inc. (REGN), a biotechnology company, on Tuesday announced a major expansion of its manufacturing capacity through a new agreement with FujiFilm Diosynth Biotechnologies. The total investment is expected to be over $3 billion. - 2025-04-22 11:38:18
CreativeOne Wealth LLC Invests $318,000 in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): CreativeOne Wealth LLC bought a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 446 shares of the biopharmaceutical company’s stock, valued at approximately $318,000. Several other hedge funds have also bought […] - 2025-04-21 08:12:54
Regeneron's SLBA For EYLEA HD Injection 8 Mg Gets Acceptance From FDA For Priority Review: (RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN), Thursday announced that the U.S. Food and Drug Administration has accepted for Priority Review the supplemental Biologics License Application for EYLEA HD (aflibercept) Injection 8 mg for the treatment of retinal vein occlusion. - 2025-04-17 11:52:05
The Goldman Sachs Group Has Lowered Expectations for Regeneron Pharmaceuticals (NASDAQ:REGN) Stock Price: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price reduced by equities researchers at The Goldman Sachs Group from $1,019.00 to $917.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s price target points to a potential upside […] - 2025-04-16 05:42:54
3 Growth Stocks That Have Turned $1,000 Into More Than $100,000 in 20 Years: Three stocks which have generated 100-bagger returns for investors over the past 20 years are Booking Holdings (NASDAQ: BKNG), Apple (NASDAQ: AAPL), and Regeneron Pharmaceuticals (NASDAQ: REGN). Here's a look at how much a $1,000 investment into each of these stocks back then wou - 2025-04-05 07:23:00
Blair William & Co. IL Decreases Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Blair William & Co. IL reduced its position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 38.6% in the 4th quarter, HoldingsChannel.com reports. The firm owned 1,255 shares of the biopharmaceutical company’s stock after selling 788 shares during the period. Blair William & Co. IL’s holdings in Regeneron Pharmaceuticals were worth $894,000 at the […] - 2025-04-04 08:23:06
Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $1,000.00 Price Target at JPMorgan Chase & Co.: Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its price objective dropped by analysts at JPMorgan Chase & Co. from $1,100.00 to $1,000.00 in a report released on Monday,Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 62.07% […] - 2025-04-02 05:54:52
Regeneron Pharmaceuticals (NASDAQ:REGN) Sets New 12-Month Low After Analyst Downgrade: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) shares reached a new 52-week low on Monday after JPMorgan Chase & Co. lowered their price target on the stock from $1,100.00 to $1,000.00. JPMorgan Chase & Co. currently has an overweight rating on the stock. Regeneron Pharmaceuticals traded as low as $618.51 and last traded at […] - 2025-04-02 05:12:49
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Receives $973.13 Consensus Price Target from Analysts: Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Free Report) have been given an average recommendation of “Moderate Buy” by the twenty-five analysts that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, six have issued a hold recommendation, sixteen have issued a buy recommendation and […] - 2025-04-01 05:56:47
Independent Advisor Alliance Has $340,000 Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Independent Advisor Alliance raised its holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 117.3% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 478 shares of the biopharmaceutical company’s stock after buying an additional 258 shares during the quarter. Independent Advisor Alliance’s holdings […] - 2025-03-19 07:42:48
CGGR, SHOP, NET, REGN: ETF Inflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Growth ETF (Symbol: CGGR) where we have detected an approximate $214.1 million dollar inflow -- that's a 2.2% increase week over week i - 2025-03-18 15:20:48
Nasdaq 100 Movers: REGN, APP: In early trading on Wednesday, shares of Applovin topped the list of the day's best performing components of the Nasdaq 100 index, trading up 9.3%. Year to date, Applovin has lost about 13.0% of its value. And the worst performing Nasdaq 100 component thus far on the day is Re - 2025-03-12 14:53:06
Jones Financial Companies Lllp Has $578,000 Holdings in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Jones Financial Companies Lllp increased its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 107.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 812 shares of the biopharmaceutical company’s stock after acquiring an additional 421 shares during […] - 2025-03-10 08:06:59

REGN institutional holdings

The following institutional investment holdings of REGN have been identified

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-17	IE00B53SZB19 (iShares NASDAQ 100 UCITS ETF USD (Acc))	124,756	USD 63,483,338
2025-06-17	IE00BYVQ9F29 (iShares NASDAQ 100 UCITS ETF)	124,756	USD 63,483,338
2025-06-17	IE00B5BMR087 (iShares Core S&P 500 UCITS ETF USD (Acc))	244,494	USD 124,413,217
2025-06-17	IE00BD8KRH84 (iShares Core S&P 500 UCITS ETF GBP Hedged (Dist))	244,494	USD 124,413,217
2025-06-17	IE00BL3J3G74 (iShares Core S&P 500 UCITS ETF MXN Hedged (Acc))	244,494	USD 124,413,217
2025-06-17	IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc))	154,936	USD 78,840,733
2025-06-17	IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist))	154,936	USD 78,840,733
2025-06-17	IE00BKBF6H24 (iShares Core MSCI World UCITS ETF)	154,936	USD 78,840,733
2025-06-17	IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist))	154,936	USD 78,840,733
2025-06-17	IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist))	11,024	USD 5,609,673
2025-06-17	IE0031442068 (iShares Core S&P 500 UCITS ETF USD (Dist))	38,159	USD 19,417,589
2025-06-17	IE00B6R52259 (iShares MSCI ACWI UCITS ETF)	26,397	USD 13,432,377
2025-06-17	IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc))	30,023	USD 15,277,504
2025-06-17	IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist))	30,023	USD 15,277,504
2025-06-17	IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc))	30,023	USD 15,277,504
2025-06-17	IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc))	44,434	USD 22,610,685
2025-06-17	IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist))	44,434	USD 22,610,685
2025-06-17	IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist))	11,450	USD 5,826,447
2025-06-17	IE00B3ZW0K18 (iShares S&P 500 EUR Hedged UCITS ETF (Acc))	16,063	USD 7,091,020
2025-06-17	IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP)	2,333	USD 1,187,170
2025-06-17	IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP)	2,333	USD 1,187,170
2025-06-17	IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist))	8,254	USD 4,200,130
2025-06-17	IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF)	8,254	USD 4,200,130
2025-06-17	IE0003WV2ME7 (iShares S&P 500 Equal Weight UCITS ETF GBP Hedged (Acc))	13,133	USD 6,682,858
2025-06-17	IE000MLMNYS0 (iShares S&P 500 Equal Weight UCITS ETF USD (Acc))	13,133	USD 6,682,858
2025-06-17	IE00B8FHGS14 (iShares Edge MSCI World Minimum Volatility UCITS ETF USD (Acc))	24,878	USD 12,659,419
2025-06-17	IE00BGPP8L80 (iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc))	24,878	USD 12,659,419
2025-06-17	IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc))	6,870	USD 3,032,765
2025-06-17	IE00B43HR379 (iShares S&P 500 Health Care Sector UCITS ETF USD (Acc))	49,876	USD 25,379,901
2025-06-17	IE00BMBKBZ46 (iShares S&P 500 Health Care Sector UCITS ETF)	49,876	USD 25,379,901
2024-11-22	IE00BP3QZ825 (iShares Edge MSCI World Momentum Factor UCITS ETF)	10,333	USD 7,625,754 -0.9%
2025-06-17	IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc))	4,106	USD 2,089,379
2025-06-17	IE00B6SPMN59 (iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Acc))	16,196	USD 8,241,497
2025-06-17	IE00BD93YH54 (iShares Edge S&P 500 Minimum Volatility UCITS ETF USD (Dist))	16,196	USD 8,241,497 -2.7%
2025-06-17	IE00B57X3V84 (iShares Dow Jones Global Sustainability Screened UCITS ETF USD (Acc))	8,028	USD 4,085,128
2025-06-17	IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD)	2,479	USD 1,261,464
2025-06-17	IE00BKVL7778 (iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc))	9,209	USD 4,686,092
2025-06-17	IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF)	2,103	USD 1,070,133
2025-06-17	IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc))	2,103	USD 1,070,133
2025-06-17	IE00BMXC7V63 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD (Acc))	3,501	USD 1,781,519
2025-06-17	IE000G4PH2B1 (iShares S&P 500 Paris-Aligned Climate UCITS ETF USD Dist)	3,501	USD 1,781,519
2025-06-17	IE00B3Y8X563 (iShares S&P 500 GBP Hedged UCITS ETF (Acc))	2,559	USD 963,680
2025-06-17	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	51,800	USD 26,358,948
2025-06-17	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	51,800	USD 26,358,948
2025-06-17	IE000R9FA4A0 (iShares S&P 500 ESG UCITS ETF USD (Acc))	1,730	USD 880,328
2025-06-17	IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist))	693	USD 352,640
2025-06-17	IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc))	693	USD 352,640
2025-06-17	IE00BKVL7331 (iShares Edge MSCI USA Minimum Volatility ESG UCITS ETF USD (Acc))	2,199	USD 1,118,983
2025-06-17	IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc))	613	USD 230,846
2025-06-17	IE000NITTFF2 (iShares Russell 1000 Growth UCITS ETF)	99	USD 50,377
2025-06-17	IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF)	683	USD 347,551
2024-11-12	IE000F9IDGB5 (iShares MSCI World Swap UCITS ETF USD (Acc))	52	USD 42,692
2025-06-17	IE000YNE6S57 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Dist))	17	USD 8,651 -2.7%
2025-06-17	IE0001YGXFO5 (iShares MSCI World Climate Transition Aware UCITS ETF USD (Acc))	17	USD 8,651
2025-02-14	IE0007O06KL9 (iShares Russell 2000 Swap UCITS ETF)	45 200.0%	USD 30,312 200.1%
2025-06-17	IE000YG82CF0 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Dist))	16	USD 8,142
2025-06-17	IE000MGAVJV3 (iShares MSCI USA Climate Transition Aware UCITS ETF USD (Acc))	16	USD 8,142
2025-06-17	IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc))	26,397	USD 13,432,377
2025-06-17	IE0009VWHAE6 (iShares US Equity Enhanced Active UCITS ETF USD (Acc))	2,153	USD 1,095,576
2024-11-08	IE000X08RX14 (iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc))	2,668	USD 2,210,225 0.5%
2025-06-17	IE00B27YCN58 (iShares MSCI World Islamic UCITS ETF USD (Dist) USD)	4,226	USD 2,150,442
2025-06-17	IE00B296QM64 (iShares MSCI USA Islamic UCITS)	2,269	USD 1,154,603
2025-06-17	IE0002W8NB38 (iShares MSCI USA Swap UCITS ETF USD (Acc))	19,501	USD 9,923,279
2025-06-17	IE000D8XC064 (iShares World Equity Enhanced Active UCITS ETF USD (Acc))	606	USD 308,369
2025-06-17	IE000WHL2ZK1 (iShares U.S. Equity High Income UCITS ETF USD Inc)	228	USD 116,020
2025-06-17	IE000KJPDY61 (iShares World Equity High Income UCITS ETF USD Inc)	155	USD 78,873
Total =	2,337,576	USD 1,190,777,378

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.